# Efficacy of Pregabalin in Migraine Prevention

> **NCT00447369** · PHASE3 · WITHDRAWN · sponsor: **Hospital Militar del General Luis Felipe Brieba Aran** · enrollment: 70 (estimated)

## Conditions studied

- Migraine Disorders

## Interventions

- **DRUG:** Pregabalin
- **DRUG:** sodium valproate

## Key facts

- **NCT ID:** NCT00447369
- **Lead sponsor:** Hospital Militar del General Luis Felipe Brieba Aran
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-05
- **Primary completion:** —
- **Final completion:** 2008-03
- **Target enrollment:** 70 (ESTIMATED)
- **Why stopped:** Because we did not find funds to do it
- **Last updated:** 2008-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00447369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00447369, "Efficacy of Pregabalin in Migraine Prevention". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00447369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*